Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2015 (2015), Article ID 953479, 6 pages
http://dx.doi.org/10.1155/2015/953479
Research Article

Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire

1Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
2Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

Received 6 January 2015; Revised 21 May 2015; Accepted 24 May 2015

Academic Editor: Lionel Larue

Copyright © 2015 Erica H. Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. Albertsen, P. C. Albertsen, D. G. Fryback et al., “The impact of co-morbidity on life expectancy among men with localized prostate cancer,” Journal of Urology, vol. 156, no. 1, pp. 127–132, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Yancik, M. N. Wesley, L. A. G. Ries, R. J. Havlik, B. K. Edwards, and J. W. Yates, “Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older,” The Journal of the American Medical Association, vol. 285, no. 7, pp. 885–892, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Miller, D. A. Taub, R. L. Dunn, J. E. Montie, and J. T. Wei, “The impact of co-morbid disease on cancer control and survival following radical cystectomy,” Journal of Urology, vol. 169, no. 1, pp. 105–109, 2003. View at Google Scholar · View at Scopus
  4. C. K. Wells, J. K. Stoller, A. R. Feinstein, and R. I. Horwitz, “Comorbid and clinical determinants of prognosis in endometrial cancer,” Archives of Internal Medicine, vol. 144, no. 10, pp. 2004–2009, 1984. View at Publisher · View at Google Scholar · View at Scopus
  5. J. F. Piccirillo, R. M. Tierney, I. Costas, L. Grove, and E. L. Spitznagel Jr., “Prognostic importance of comorbidity in a hospital-based cancer registry,” Journal of the American Medical Association, vol. 291, no. 20, pp. 2441–2447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-Y. Ma, T. Ji, A. Ow et al., “Surgical site infection in elderly oral cancer patients: is the evaluation of comorbid conditions helpful in the identification of high-risk ones?” Journal of Oral and Maxillofacial Surgery, vol. 70, no. 10, pp. 2445–2452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. T. A. Peters, B. A. C. van Dijk, J. L. N. Roodenburg, B. F. A. M. van der Laan, and G. B. Halmos, “Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer,” Annals of Surgical Oncology, vol. 21, no. 3, pp. 963–970, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. I. K. Lægreid, K. Aasarod, A. Bye, T. Leivestad, and M. Jordhoy, “The impact of nutritional status, physical function, comorbidity and early versus late start in dialysis on quality of life in older dialysis patients,” Renal Failure, vol. 36, no. 1, pp. 9–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Baijal, T. Gupta, C. Hotwani et al., “Impact of comorbidity on therapeutic decision-making in head and neck cancer: audit from a comprehensive cancer center in India,” Head and Neck, vol. 34, no. 9, pp. 1251–1254, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Charlson, P. Pompei, K. A. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Delaney, I. Shimizu, L. H. Goldberg, and D. F. MacFarlane, “Life expectancy after Mohs micrographic surgery in patients aged 90 years and older,” Journal of the American Academy of Dermatology, vol. 68, no. 2, pp. 296–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Pascual, I. Belinchon, and J. M. Ramos, “Mortality after dermatologic surgery for nonmelanoma skin cancer in patients aged 80 years and older,” Journal of the American Academy of Dermatology, vol. 69, no. 6, pp. 1051–1052, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Charles Jr., C. C. Otley, and G. R. Pond, “Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: implications for selecting surgical candidates,” Journal of the American Academy of Dermatology, vol. 47, no. 3, pp. 419–422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Paleri and R. G. Wight, “A cross-comparison of retrospective notes extraction and combined notes extraction and patient interview in the completion of a comorbidity index (ACE-27) in a cohort of United Kingdom patients with head and neck cancer,” Journal of Laryngology and Otology, vol. 116, no. 11, pp. 937–941, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. A. Sharabiani, P. Aylin, and A. Bottle, “Systematic review of comorbidity indices for administrative data,” Medical Care, vol. 50, no. 12, pp. 1109–1118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. B. S. Linn, M. W. Linn, and L. Gurel, “Cumulative illness rating scale,” Journal of the American Geriatrics Society, vol. 16, no. 5, pp. 622–626, 1968. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Litwin, S. Greenfield, E. P. Elkin, D. P. Lubeck, J. M. Broering, and S. H. Kaplan, “Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice,” Cancer, vol. 109, no. 9, pp. 1777–1783, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. H. Kaplan and A. R. Feinstein, “The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus,” Journal of Chronic Diseases, vol. 27, no. 7-8, pp. 387–404, 1974. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Mayr, M. May, T. Martini et al., “Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder,” BJU International, vol. 110, no. 6, pp. E222–E227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Kallogjeri, S. M. Gaynor, M. L. Piccirillo, R. A. Jean, E. L. Spitznagel Jr., and J. F. Piccirillo, “Comparison of comorbidity collection methods,” Journal of the American College of Surgeons, vol. 219, no. 2, pp. 245–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. V. S. Nesic, Z. M. Petrovic, S. B. Sipetic, S. D. Jesic, I. A. Soldatovic, and D. A. Kastratovic, “Comparison of the Adult Comorbidity Evaluation 27 and the Charlson Comorbidity indices in patients with laryngeal squamous cell carcinoma,” Journal of Laryngology and Otology, vol. 126, no. 5, pp. 516–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. B. Owen, N. Khalid, A. Ho et al., “Can patient comorbidities be included in clinical performance measures for radiation oncology?” Journal of Oncology Practice, vol. 10, no. 3, pp. e175–e181, 2014. View at Publisher · View at Google Scholar
  23. V. Paleri and R. G. Wight, “Applicability of the adult comorbidity evaluation—27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study,” Journal of Laryngology and Otology, vol. 116, no. 3, pp. 200–205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. F. Piccirillo, C. M. Creech, R. Zequeira, S. Anderson, and A. S. Johnston, “Inclusion of comorbidity into oncoogy data registries,” Journal of Registry Management, vol. 26, pp. 66–70, 1999. View at Google Scholar
  25. N. Daver, K. Naqvi, E. Jabbour et al., “Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes,” American Journal of Hematology, vol. 89, no. 5, pp. 509–516, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Chen, D. Bertenthal, A. Sahay, S. Sen, and M.-M. Chren, “Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma,” Archives of Dermatology, vol. 143, no. 11, pp. 1386–1392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Schubert-Fritschle, A. Schlesinger-Raab, R. Hein et al., “Quality of life and comorbidity in localized malignant melanoma: results of a German population-based cohort study,” International Journal of Dermatology, vol. 52, no. 6, pp. 693–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. F. Sobanko and S. T. Ross, “Mistaken conclusions in a nonmelanoma skin cancer article published in JAMA,” Dermatologic Surgery, vol. 40, no. 5, pp. 489–496, 2014. View at Publisher · View at Google Scholar · View at Scopus